On May 5th, 2017, Whitney Grither was awarded the 2017 Ceil M. DeGutis Prize in Chemical Biology/Medicinal Chemistry. Whitney presented her research entitled: Selective Small Molecule Inhibition of Discoidin Domain Receptor 2. Whitney graduated this Spring from the Biochemistry graduate program. She finished her PhD work in the laboratory of Dr. Greg Longmore with the express purpose of identifying novel modes of inhibiting an underappreciated collagen receptor, DDR2, which they had just shown was critical for breast cancer metastasis in experimental mouse models and humans (Nature Cell Biology, 2013). (more…)
Congratulations to Roberto Galletto, whose promotion with tenure was officially approved by the Board of Trustees on March 3, 2017.
Congratulations to Joseph Stodola. Joe received the Olin Biomedical Science Fellowship. These Fellowships were created by a generous gift from the Olin Foundation. The Olin Fellowships are presented to Ph.D. and M.D./Ph.D. students conducting research in the biomedical sciences in any Washington University graduate program who have made significant contributions, and demonstrated the potential to become outstanding research scientists. Joe obtained his PhD degree last summer in Peter Burgers’ lab. Next month, he will join Sigma-Aldrich.
Congratulations to Linda Pike! The Journal of Biological Chemistry included one of her publications among their collection “Highlights of 2016.” The paper is: Ronan et al. Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins. J. Biol. Chem. 291 (11): 5528-5540.
The January 2017 issue of Nature Structural & Molecular Biology is now available, and it features a News and Views piece highlighting Dr. Weikai Li’s recent publication, Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer.
School of Medicine investigators are harnessing new technologies to create precision and personalized approaches to diseases — advances that could not occur without prior investments in basic research.
“Basic research is a key driver of biomedical discovery and an essential part of the robust research environment at the School of Medicine,” said David H. Perlmutter, MD, executive vice chancellor for medical affairs and dean of the School of Medicine. (more…)